Skip to content

Depression: all studies

Page 609 of 1,034: studies 6,081 to 6,090 of 10,336, newest first. Back to the depression overview

Research

Mindfulness program for workers in Japan: online program focused on informal training in the workplace.

Frontiers in Psychology 2025 Mina Nakano

Mindfulness has gained prominence as an effective tool for managing stress and preventing depression. However, many workers in Japan find it challenging to commit to lengthy mindfulness sessions. This study addressed this issue by developing a six-session online mindfulness program tailored to Japanese workers, which emphasizes decentering (the ability to view thoughts and emotions as separate...

DOI: 10.3389/fpsyg.2025.1526275 (opens in new tab) Full text (opens in new tab) Mental health program Stress-management Worker Brief mindfulness +5

Potential therapeutic effects of psychedelics in small doses: Is there a role for microdosing in psychiatry?

International review of neurobiology 2025 Iva Totomanova, Eline Haijen, Petra P M Hurks et al.

Clinical trials using full doses of psychedelics have provided preliminary evidence supporting their safety and efficacy in treating a variety of physical and psychological conditions. Anecdotal reports indicate that even very small amounts of these substances may provide therapeutic benefits, though robust clinical studies are still needed. This chapter reviews the current experimental studies...

Psychedelics for the treatment of end-of-life distress in patients with a life-threatening disease.

International review of neurobiology 2025 Stephan Tap, Tijmen Bostoen, Joost J. Breeksema et al. 4 citations

Patients with a life-threatening disease (LTD) sometimes suffer from end-of-life distress (EOLD) which refers to the physical, psychological, emotional, and spiritual suffering related to chronic illness and the possibility of death. Palliative care interventions seek to improve the quality of life of patients with EOLD and their significant others. Currently, a range of psychological and...

Evaluation of the peak experience scale as a rapid assessment tool for the strength of a psychoactive experience with 5-MeO-DMT.

Frontiers in Psychology 2025 Johannes T. Reckweg, Natasha L. Mason, Eef L. Theunissen et al. 2 citations

A three-item Peak Experience Scale (PES) was developed to rapidly evaluate the strength of the psychoactive experience, and to guide the dosing regimen, of the psychedelic 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT; mebufotenin). This paper aims to compare the PES with a range of established questionnaires designed to evaluate the psychedelic experience. Data were gathered from three separate...

Impact of a Mindfulness-Based Intervention on Symptoms and Emotion Regulation Strategies in Young Adolescents From the General Population: A Randomized Controlled Trial.

Depression and Anxiety 2025 Camille Piguet, Zeynep Celen, Ben Meuleman et al. 2 citations

Adolescence is marked by major puberty-induced changes including increased reactivity to stress and a peak incidence of mental disorders. The implementation of early interventions during this developmental period is essential to prevent mental disorders. In this clinical trial, we examined the effects of a mindfulness-based intervention (MBI) on internalizing symptoms, affects, and...

DOI: 10.1155/da/2679049 (opens in new tab) Full text (opens in new tab) Anxiety Emotion regulation Internalized symptoms Randomized controlled trial +16

Correlation analysis between clinical effective emotional treatment and plasma N-methyl-D-aspartate receptor function-related indexes.

Frontiers in Neuroscience 2025 Zuxing Feng, Yanli Li, Ying Cai et al. 2 citations Retracted

With the use of ketamine, Glutamate (Glu) system has gradually become the focus of antidepressant effects. N-methyl-D-aspartate receptor (NMDAR), as one of the major ionic glutamate receptors, plays a dominant role in antidepressant effects, especially in synaptic plasticity. Few studies have been conducted on changes of NMDAR-related indicators and inflammatory cytokines in major depressive...

DOI: 10.3389/fnins.2025.1608722 (opens in new tab) Full text (opens in new tab) N-methyl-d-aspartate receptor nmdar Metabolism Antidepressant therapy Depression recovery +12

Chronic low back pain management: clinical and psychophysiological outcomes of multimodal approaches-a randomised controlled trial on yoga and mindfulness.

BMJ open sport & exercise medicine 2025 Yusra Saleem, Shamoon Noushad, Sadaf Ahmed et al. 1 citation

Chronic low back pain (CLBP) presents as a widespread medical issue which severely affects personal health status while generating substantial economic expenses. Traditional treatment methods often have limited efficacy, necessitating the exploration of alternative therapies such as yoga and mindfulness-based stress reduction (MBSR). This study aims to compare the efficacy of Sphinx pose yoga...

DOI: 10.1136/bmjsem-2025-002697 (opens in new tab) Full text (opens in new tab) Exercise physiology Intervention Physical activity Quality of life +2

Meditation for subjective cognitive decline, mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials.

Frontiers in Public Health 2025 Jiaxin Shi, Hao Tian, Jingwen Wei et al. 2 citations

Meditation has gained increasing recognition as a simple, cost-effective, and non-invasive therapeutic approach for older adults with subjective cognitive decline (SCD), mild cognitive impairment (MCI), and Alzheimer's disease (AD). This meta-analysis aimed to systematically evaluate its effectiveness on this population. A comprehensive search across nine databases was performed from inception...

DOI: 10.3389/fpubh.2025.1524898 (opens in new tab) Full text (opens in new tab) Alzheimer’s disease Mild cognitive impairment Subjective cognitive decline Meditation: meditation +9

Systematic review of parenteral ketamine for managing acute agitation in emergency settings.

Asian Journal of Psychiatry 2025 Christopher Peter, Satish Suhas, Guru S Gowda et al. 6 citations

Agitation, a significant psychiatric issue often linked to conditions like schizophrenia, bipolar disorder, and major depression, invariably pose challenges in emergency settings. Acute agitation occurs in 2.6 % of emergency cases and up to 12.2 % among patients with schizophrenia or bipolar disorder. With limited available options for effective management of acute agitation, ketamine is...

DOI: 10.1016/j.ajp.2024.104344 (opens in new tab) Full text (opens in new tab) Aggression Emergency medicine Psychiatric emergencies Sedation +2

Effects of repeated intravenous esketamine administration on affective biases.

The World Journal of Biological Psychiatry 2025 Christine Reif-Leonhard, Shannon N Millard, Dorsa Ferdowssian et al. 3 citations

While neuropsychological effects of conventional antidepressants are well-documented, more research is needed for rapid-acting antidepressants. This study examines the effects of esketamine on emotion processing and cognitive functioning, both acutely and sub-chronically. Eighteen treatment-resistant depression (TRD) patients received repeated intravenous esketamine infusions. Mood state was...

DOI: 10.1080/15622975.2024.2441304 (opens in new tab) Full text (opens in new tab) Ema Rapid acting antidepressant Dosing Prediction +8